Ultragenyx Pharmaceutical Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $1.49B
Liabilities Breakdown FY2023
Total Liabilities: $1.22B
Asset Breakdown
Total Assets: $1.49B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $214.0M | 14.4% |
| Accounts Receivable | $73.4M | 4.9% |
| Inventory | $34.0M | 2.3% |
| Property, Plant & Equipment | $290.6M | 19.5% |
| Goodwill | $44.4M | 3.0% |
| Intangible Assets | $166.3M | 11.2% |
| Other Assets | $668.4M | 44.8% |
Liabilities Breakdown
Total Liabilities: $1.22B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $42.1M | 3.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.17B | 96.5% |